Rafael Holdings Inc
Change company Symbol lookup
Select an option...
RFL Rafael Holdings Inc
PLL Piedmont Lithium Inc
PPIH Perma-Pipe International Holdings Inc
PANL Pangaea Logistics Solutions Ltd
JAN Janone Inc
IMCC IM Cannabis Corp
FSNB Fusion Acquisition Corp II
SCPL Sciplay Corp
MKNGF Mkango Resources Ltd
CVX Chevron Corp

Real Estate : Real Estate Management & Development | Small Cap Value
Company profile

Rafael Holdings, Inc. is a holding company. The Company owns interests in clinical and early-stage pharmaceutical companies and commercial real estate assets. The Company is focused on the discovery of cancer and immune metabolism therapeutics. The Company operates through two segments: Pharmaceuticals and Real Estate. The Pharmaceuticals segment is comprised of preferred and common equity interests and the Warrant to purchase equity interests in Rafael Pharmaceuticals, a majority equity interest in LipoMedix, Barer, Levco, Farber and Rafael Medical Devices. The Real Estate segment consists of the Company's real estate holdings associated with a portion of an office building in Israel.

Closing Price
Day's Change
-0.03 (-1.46%)
B/A Size
Day's High
Day's Low

10-day average volume:

First Solar stock price target raised to $123 from $104 at Argus Research

9:01 am ET August 5, 2022 (MarketWatch)

(END) Dow Jones Newswires

August 05, 2022 09:01 ET (13:01 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.